Prologis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated August 4, 2026, discloses a material definitive agreement between Prologis, Inc. ("Prologis") and SEGRO plc ("SEGRO"). Prologis has announced a recommended offer to acquire the entire issued and to be issued share capital of SEGRO (the "Combination"). The transaction is expected to be completed in the first half of 2027, subject to regulatory and shareholder approvals.
Key Financial Metrics and Transaction Terms
The filing details the financial structure of the proposed acquisition rather than Prologis's standalone operating results for the period.
- Transaction Value: Approximately £14.0 billion for SEGRO's entire share capital, valuing each SEGRO ordinary share at 1,031.7 pence.
- Consideration Structure:
- Stock: 0.0920 shares of Prologis common stock for each SEGRO ordinary share.
- Cash Alternative: Shareholders may elect cash for up to 25% of the consideration (258 pence per share). The maximum aggregate cash available is approximately £3.5 billion.
- Financing: Prologis, L.P. entered into a Term Loan Facility of up to £3,575,000,000 to fund the cash portion of the deal. The facility matures one year after the initial borrowing, with two one-year extension options available. The initial spread is 70 basis points.
- Ownership Impact: Assuming full uptake of the cash alternative, SEGRO shareholders would hold approximately 8.9% of the combined group. If no cash is elected, they would hold approximately 11.5%.
- Dividends: SEGRO shareholders are entitled to retain the 2026 interim dividend (up to 10.14 pence) and final dividend (up to 22.56 pence). If the deal extends into 2027, they are also entitled to 2027 interim (up to 10.55 pence) and final (up to 23.52 pence) dividends.
Note: The filing does not provide Prologis's standalone revenue, profit, cash flow, or margin data for the reporting period.
Material Changes and Conditions
The Combination is subject to several material conditions that must be satisfied or waived:
- Approval by a majority in number of SEGRO shareholders present and voting, representing not less than 75% in value of shares voted.
- Sanction by the High Court of Justice in England and Wales.
- Receipt of required antitrust and regulatory approvals.
- Listing approval for New Prologis Shares on the New York Stock Exchange.
- Admission of Prologis common stock to trading on the London Stock Exchange (secondary listing).
- Completion by the "Long Stop Date."
Outlook, Risks, and Management Commentary
Management anticipates the Combination will be completed in the first half of 2027. Prologis intends to implement the deal via a court-sanctioned scheme of arrangement but reserves the right to switch to a takeover offer.
Key Risks Disclosed:
- Completion Uncertainty: The deal may be delayed or fail to close due to regulatory hurdles or failure to meet conditions.
- Integration Challenges: Combining two independent public companies may result in operational difficulties, higher-than-expected costs, or failure to realize anticipated synergies.
- Dilution: Continuing Prologis stockholders will hold a proportionally smaller ownership interest (estimated at 91.1% with full cash uptake, or 88.5% with no cash uptake).
- Regulatory Constraints: Governmental approvals may impose divestitures or operational restrictions that reduce anticipated benefits.
Investor Verification Checklist
- Verify the status of regulatory approvals required in the UK, US, and other jurisdictions where the companies operate.
- Confirm the final percentage of SEGRO shareholders electing the cash alternative versus stock, as this impacts dilution and the final ownership structure.
- Monitor the "Long Stop Date" to ensure the transaction closes before the deadline.
- Review the full text of the Co-operation Agreement (Exhibit 2.1) and Term Loan Credit Agreement (Exhibit 10.1) for specific covenants and termination rights.
- Assess the impact of the £3.575 billion term loan on Prologis's leverage ratios and credit ratings.